Monika Drobniene
Vilnius, VL, Lithuania
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Comprehensive genomic profiling can predict response to neoadjuvant chemotherapy in triple-negative breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: October 09, 2024
Ivabradine for the Prevention of Anthracycline-Induced Cardiotoxicity in Female Patients with Primarily Breast Cancer: A Prospective, Randomized, Open-Label Clinical Trial.
Journal: Medicina (Kaunas, Lithuania)
Published: November 10, 2023
Analysis of Intrinsic Breast Cancer Subtypes: The Clinical Utility of Epigenetic Biomarkers and TP53 Mutation Status in Triple-Negative Cases.
Journal: International journal of molecular sciences
Published: October 06, 2022
Development of a Cardio-Oncology Service in Lithuania: Prediction, Prevention, Monitoring and Treatment of Cancer Treatment-Induced Cardiotoxicity.
Journal: Journal of cardiovascular development and disease
Published: April 05, 2022
Nongenotoxic ABCB1 activator tetraphenylphosphonium can contribute to doxorubicin resistance in MX-1 breast cancer cell line.
Journal: Scientific reports
Published: June 12, 2020
Delays in diagnosis and treatment of breast cancer: a multinational analysis.
Journal: European journal of public health
Published: September 14, 2013
Targeted therapy in patients with non-small cell lung cancer previously treated with chemotherapy.
Journal: Medicina (Kaunas, Lithuania)
Published: December 14, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026